A quarterly analytical discussion on study startup
The ChromoReport is a quarterly analytical discussion on study startup utilizing anonymized aggregated clinical data from leading Pharmas and CROs, representing over 70 percent of clinical trial sites engaged in phase II & III studies.
The trend to outsource clinical trial operations to contract research organizations (CRO) is rooted in intense competition to improve productivity, driving sponsors to contain operational and infrastructure costs while completing projects better, faster and more efficiently. These external service providers can achieve economies of scale unavailable to individual firms when they combine the volumes of multiple companies.
Nevertheless, irrespective of organizational structure – expertise, experience and project management are equally important to both sponsors & CROs who face similar challenges and see the same opportunities for improvement.
But what do the industry metrics have to say about economies of scale in clinical trials?
Download the December 2017 edition of the ChromoReport today! Fill out the form to get your copy.